Exhibit 32.1
Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
The undersigned, the Chief Executive Officer and the Chief Financial Officer of Angiotech Pharmaceuticals, Inc. (the “Company”), each hereby certifies that to his knowledge on the date hereof:
(a)
The Form 10-K/A of the Company for the year-ended December 31, 2008, filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b)
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
|
Date: November 5, 2009 |
| /s/ William L. Hunter . |
|
| William L. Hunter, M.D. |
|
| Chief Executive Officer |
|
|
|
Date: November 5, 2009 |
| /s/ K. Thomas Bailey. |
|
| K. Thomas Bailey |
|
| Chief Financial Officer |
